Yana Kipnis
Lawyers
Filters
Marvell Technology $1 billion senior notes offering
The senior notes are due 2030 and 2035
Airbus acquisition of certain assets and sites from Spirit AeroSystems
We are advising Airbus on the transaction
Nova Biomedical $2.2 billion acquisition by Advanced Instruments
We are advising Nova Biomedical on the transaction
GH Research $150 million follow-on offering
We advised GH Research on the offering of shares
Airbus potential acquisition of certain Spirit AeroSystems activities
We are advising Airbus on the transaction
Roche $295 million acquisition of LumiraDx's point of care technology platform
We are advising Roche on the acquisition
GSK exclusive license agreement for HS-20089 with Hansoh Pharma
We advised GSK on the transaction
Roche $7.1 billion acquisition of Telavant and rights to RVT 3101 from Roivant
We are advising Roche on the acquisition
Marvell Technology $1 billion senior notes offering
The senior notes are due 2029 and 2033
Intuit $4 billion notes offering
The investment-grade offering comprises four tranches of notes